Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2ˉ· production in cancer cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2ˉ· production in cancer cells
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 119, Issue 8, Pages 994-1008
Publisher
Springer Nature America, Inc
Online
2018-10-11
DOI
10.1038/s41416-018-0288-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial Uncoupling Proteins: Subtle Regulators of Cellular Redox Signaling
- (2018) Petr Ježek et al. ANTIOXIDANTS & REDOX SIGNALING
- Lowcatalaseexpression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL
- (2018) Chiara Cavallini et al. BLOOD
- Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease
- (2018) Nadee Nissanka et al. FEBS LETTERS
- UCP2 inhibition induces ROS/Akt/mTOR axis: Role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism
- (2017) Ilaria Dando et al. FREE RADICAL BIOLOGY AND MEDICINE
- PGC-1α in Melanoma: A Key Factor for Antioxidant Response and Mitochondrial Function
- (2017) Margalida Torrens-Mas et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism
- (2017) Matilda Eriksson et al. MOLECULAR AND CELLULAR BIOLOGY
- AMPK Maintains Cellular Metabolic Homeostasis through Regulation of Mitochondrial Reactive Oxygen Species
- (2017) Rebecca C. Rabinovitch et al. Cell Reports
- Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: Involvement in cancer invasion and metastasis
- (2016) Marco Cordani et al. CANCER LETTERS
- Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy
- (2016) Chao He et al. CHEMOTHERAPY
- The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition
- (2016) Jessica Brandi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mutant p53 and mTOR/PKM2 regulation in cancer cells
- (2016) Ilaria Dando et al. IUBMB LIFE
- Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition
- (2016) Marco Cordani et al. Molecular Oncology
- Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy
- (2016) Barbara Marengo et al. Oxidative Medicine and Cellular Longevity
- Biochemical Basis of Sestrin Physiological Activities
- (2016) Allison Ho et al. TRENDS IN BIOCHEMICAL SCIENCES
- ROS homeostasis and metabolism: a dangerous liason in cancer cells
- (2016) E Panieri et al. Cell Death & Disease
- Oncogenic Intra-p53 Family Member Interactions in Human Cancers
- (2016) Maria Ferraiuolo et al. Frontiers in Oncology
- Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine
- (2015) Claudia Fiorini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The antioxidant function of sestrins is mediated by promotion of autophagic degradation of Keap1 and Nrf2 activation and by inhibition of mTORC1
- (2015) Sue Goo Rhee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2015
- (2015) Andrew D. Zelenetz et al. Journal of the National Comprehensive Cancer Network
- Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities
- (2015) Madhusudhan Kollareddy et al. Nature Communications
- The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
- (2015) Kanaga Sabapathy Frontiers in Oncology
- Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression
- (2015) Fabio Valenti et al. Oncotarget
- Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells
- (2014) H E Boudreau et al. BRITISH JOURNAL OF CANCER
- Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation
- (2014) Ge Zhou et al. MOLECULAR CELL
- Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist
- (2014) V Ubertini et al. ONCOGENE
- UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation
- (2014) A. Vozza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- UCP2, a mitochondrial protein regulated at multiple levels
- (2013) Massimo Donadelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Mild oxidative stress induces S-glutathionylation of STAT3 and enhances chemosensitivity of tumoural cells to chemotherapeutic drugs
- (2013) Elena Butturini et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells
- (2013) I Dando et al. Cell Death & Disease
- Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis
- (2012) Claudia Fiorini et al. APOPTOSIS
- Mutant p53R273Hattenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species
- (2012) Eyal Kalo et al. JOURNAL OF CELL SCIENCE
- Links between mutant p53 and genomic instability
- (2011) Walter Hanel et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Analysis of the chronic lymphocytic leukemia coding genome: role ofNOTCH1mutational activation
- (2011) Giulia Fabbri et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Reactive oxygen species in cancer
- (2010) Geou-Yarh Liou et al. FREE RADICAL RESEARCH
- Pharmacological reactivation of mutant p53: from protein structure to the cancer patient
- (2010) K G Wiman ONCOGENE
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway
- (2008) N.V. Khromova et al. CANCER LETTERS
- p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
- (2008) Andrei V. Budanov et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now